Short page
Cagrilintide

Specification
| Name | Cagrilintide |
|---|---|
| Catalog sizes | 5 mg |
| Adopted bacteriostatic water | 5 mg + 2.0 mL = 2.5 mg/mL |
Overview
Cagrilintide is an investigational amylin analog. It is not FDA-approved. The TRACE vial is 5 mg. This version does not close a trial citation.
Mechanism under study
Amylin is a pancreatic signal that has been studied alongside satiety. Without a closed citation on this page, TRACE does not develop the pathway.
What published research has reported
No study is listed in this version.
This version does not close a study list. No citation is invented.
Composition and mass
5 mg vial. Adopted bacteriostatic water: 2 mL (2.5 mg/mL).
Reconstitution
| mg | mL | mg/mL | |
|---|---|---|---|
| 5 | 2.0 | 2.5 | In the catalog |
Storage and handling
Lyophilized material cool, dry, and protected from light. Dissolved: 2–8 °C, not frozen, 28-day horizon.
Regulatory status
Investigational compound. Not FDA-approved. Not a drug, a supplement, or a food.